glp 1 drugs heart failure GLP-1 reduce risk of death and hospitalization in patients with The landscape of novel antidiabetic
Description
114458, Aug
The processes of passage through the bloodbrain barrier and penetration into deeper brain regions differ between the GLP-1R agonists (Salinas et al., 2018)
Nevertheless, this building evidence has triggered calls to explore GLP-1RAs as novel treatments to reduce stroke risk and improve neurological outcomes in at-risk populations (196, 198)
After propensity matching for age, sex, race, and obesity, 69,221 patients were included in the primary analysis
